Is there a role for phosphodiesterase type-5 inhibitors in the treatment of premature ejaculation?
- 27 January 2011
- journal article
- review article
- Published by Springer Nature in International Journal Of Impotence Research
- Vol. 23 (1) , 17-23
Abstract
Premature ejaculation (PE) is considered to be the most common male sexual dysfunction. The realization that PE may co-exist with ED prompted the use of PDE5-i's alone or in combination with selective serotonin reuptake inhibitors (SSRIs) for treating ejaculatory disorders. Until recently, there was little evidence that PDE5-i's alone may have a role in the treatment of PE in the absence of ED, and current available treatments include only on-demand dapoxetine. However, available data indicate that there is clinical, anatomical, physiological, pharmacological and genetic evidence to explain the efficacy of PDE5-i's. Nine manuscripts that examined the efficacy of PDE5-i's in the treatment of PE, alone or in combination with SSRIs, were retrieved. All studies reported some significant changes in the intravaginal ejaculatory latency time and sexual satisfaction scores, although not all were clinically meaningful. Well-designed multicenter studies are urgently required to further elucidate the efficacy and safety, as well as the mechanisms of action of PDE5-i's in the treatment of PE. The aim of this review is to discuss basic rationale and to show clinical evidence sustaining the possibility to use off-label PDE5-i's to treat PE.Keywords
This publication has 55 references indexed in Scilit:
- Baseline Characteristics and Treatment Outcomes for Men with Acquired or Lifelong Premature Ejaculation with Mild or No Erectile Dysfunction: Integrated Analyses of Two Phase 3 Dapoxetine TrialsThe Journal of Sexual Medicine, 2010
- Vardenafil Increases Cell Proliferation in the Dentate Gyrus through Enhancement of Serotonin Expression in the Rat Dorsal RapheJournal of Korean Medical Science, 2009
- Improvement in duration of erection following phosphodiesterase type 5 inhibitor therapy with vardenafil in men with erectile dysfunction: the ENDURANCE studyInternational Journal Of Clinical Practice, 2009
- Identifying constructs and criteria for the diagnosis of premature ejaculation: implication for making errors of classificationBJU International, 2008
- An evidence‐based definition of lifelong premature ejaculation: report of the International Society for Sexual Medicine Ad Hoc Committee for the Definition of Premature EjaculationBJU International, 2008
- Effect of Fluoxetine Alone and in Combination with Sildenafil in Patients with Premature EjaculationUrologia Internationalis, 2007
- Correlation between ejaculatory and erectile dysfunctionInternational Journal of Andrology, 2005
- Phosphodiesterase 5 Inhibitors in Rapid EjaculationDrugs, 2004
- Assessing the quality of reports of randomized clinical trials: Is blinding necessary?Controlled Clinical Trials, 1996
- Relationship between sympathetic nervous system activity, baroreflex and cardiovascular effects after acute nitric oxide synthesis inhibition in humansJournal Of Hypertension, 1995